Updated TGA licence for sterile liquids for all clinical trial phases (I-III)

We’re proud to share a major milestone for Pure Solutions

Our expanded Therapeutic Goods Administration (TGA) licence now covers:

✅ Full manufacturing and labelling of sterile liquids for all clinical trial phases (I–III)
✅ Manufacturing licensing for non-sterile registered therapeutic commercial products

This builds on our existing TGA licence for microbiological and sterility testing — and reflects the strength of our systems, the dedication of our team, and our unwavering commitment to quality, compliance, and patient safety.

As the first company in Australia with licensed isolator units for clinical trial manufacturing, this achievement further positions us to support partners locally and globally with premium sterile GMP services, while also showcasing our state-of-the-art facility on the global stage.

A huge thank you to our team and collaborators — your hard work made this possible!